Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Sell
400
-600
-60% -$186K ﹤0.01% 4496
2025
Q4
$295K Buy
+1,000
New +$186K ﹤0.01% 4027
2025
Q3
Sell
-45,700
Closed -$1.92M 8984
2025
Q2
$1.92M Buy
45,700
+20,900
+84% +$796K ﹤0.01% 2179
2025
Q1
$939K Sell
24,800
-26,800
-52% -$1.67M ﹤0.01% 2515
2024
Q4
$3.97M Buy
51,600
+8,900
+21% +$644K 0.01% 1328
2024
Q3
$2.46M Buy
42,700
+42,500
+21,250% +$2.3M 0.01% 1563
2024
Q2
$8.27K Buy
200
+100
+100% +$4.73K ﹤0.01% 5729
2024
Q1
$6.1K Sell
100
-8,900
-99% -$399K ﹤0.01% 6106
2023
Q4
$201K Buy
9,000
+8,867
+6,667% +$160K ﹤0.01% 3858
2023
Q3
$3.42K Buy
+133
New +$2.52K ﹤0.01% 6863
2023
Q2
Sell
-333
Closed -$4.04K 8092
2023
Q1
$4.04K Buy
+333
New +$14.1K ﹤0.01% 6369
2022
Q4
Sell
-1,333
Closed -$45K 7908
2022
Q3
$45K Sell
1,333
-2,500
-65% -$125K ﹤0.01% 5490
2022
Q2
$141K Buy
3,833
+1,713
+81% +$183K ﹤0.01% 4653
2022
Q1
$325K Buy
+2,120
New +$435K ﹤0.01% 4285
2021
Q3
Sell
-367
Closed -$101K 8657
2021
Q2
$101K Buy
367
+360
+5,143% +$129K ﹤0.01% 5942
2021
Q1
$3K Buy
+7
New +$4.98K ﹤0.01% 7345

Other funds holding PRAX

Group One Trading's PRAX Position: Q1 2026 in Review

Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 98% in Q1 2026, selling an estimated $1.67M and leaving 129 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.

Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.5M in Q3 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Group One Trading held 129 shares of Praxis Precision Medicines worth $41.6K as of Q1 2026.
  • Group One Trading sold 5,410 Praxis Precision Medicines shares in Q1 2026, an estimated $1.67M.
  • Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5395 holding.
  • Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 13 quarters since.
  • Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.